Risk factors for methotrexate treatment failure in tubal ectopic pregnancy: a retrospective cohort study
Abstract Background Ectopic pregnancy (EP) accounts for approximately 2% of all pregnancies, with tubal ectopic pregnancies (TEPs) being the most common type. Methotrexate (MTX) is a noninvasive and effective medical management option for TEP, but failure rates range from 10 to 36%, posing challenge...
Saved in:
Main Authors: | Linru Fu, Xinyan Liu, Zhao Tian, Zhe Du, Xinyi Wang, Xiuqi Wang, Xiaodong Li, Tao Xu, Zhijing Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12884-024-07122-6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The predictors of successful methotrexate treatment of tubal ectopic pregnancy
by: Eiman Abdelfattah-Arafa, et al.
Published: (2024-12-01) -
Management of Ectopic Pregnancy: Comparison of Systemic Methotrexate Administration and Surgical Treatment; A Retrospective Study
by: Ali Cenk Özay, et al.
Published: (2013-08-01) -
Predictors of treatment failure of tubal pregnancy with single-dose methotrexate regimen – a systematic review and meta-analysis
by: Lili Tang, et al.
Published: (2025-12-01) -
Ipsilateral ectopic pregnancy in the distal remaining part of the previously removed Fallopian tube: a case report
by: Bassant Elshatby, et al.
Published: (2024-12-01) -
Ectopic Pregnancy: A Review of Prevalence, Clinical Presentation and Outcome in Gusau, Northwest, Nigeria
by: Shittu MA, et al.
Published: (2025-01-01)